Previous 10 | Next 10 |
BOSTON, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) announced today that Machelle Sanders and Dr. Andrew C. von Eschenbach have joined the Company’s board of directors. Ms. Sanders and Dr. von Esche...
Radius Health ([[RDUS]] +4.3%) says that its focus on postmenopausal osteoporotic fracture patients continues to gain traction. In November, a truncated sales month due to the Thanksgiving holiday, Radius added 1,326 net new patients, representing 8% increase from the previous four-month trai...
Continued growth in net new patients for the month of November 2020 Company is on-track for record quarter in net revenue for TYMLOS-SC Research Agreement reached with MGH in October 2020 Hired Head of Clinical Development for the abaloparatide molecule WALTHAM, Mass.,...
Olema Pharmaceuticals intends to raise $170 million in a U.S. IPO of its common stock. The firm is developing treatments for women's cancers, most particularly various breast cancers. It has a collaboration with major pharma firm Novartis and I value its focus on breast cancer tre...
The following slide deck was published by Radius Health, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Radius Health, Inc. 2020 Q3 - Results - Earnings Call Presentation
Image source: The Motley Fool. Radius Health (NASDAQ: RDUS) Q3 2020 Earnings Call Nov 05, 2020 , 8:30 a.m. ET Operator Continue reading For further details see: Radius Health (RDUS) Q3 2020 Earnings Call Transcript
Radius Health, Inc. (RDUS) Q3 2020 Earnings Conference Call November 5, 2020 8:20 A.M. ET Company Participants Elhan Webb - Vice President, Investor Relations Kelly Martin - President and Chief Executive Officer Dan Dolan - Head of Financial Planning and Analysis Sal Grausso - Chief Commercia...
Radius Health (RDUS): Q3 Non-GAAP EPS of $0.15 beats by $0.20; GAAP EPS of -$0.14 beats by $0.07.Revenue of $77.83M (+67.5% Y/Y) misses by $4.91M.Press Release For further details see: Radius Health EPS beats by $0.20, misses on revenue
TYMLOS ® U.S. net sales of $50 million with 8% year-over-year growth; Total Revenues of $78 million Q3 commercial pivot to focus on high risk fracture segment is gaining traction: Net New U.S. Patients increased by 7+% in September 2020 vs. previous 3-month moving average and...
Olema Pharmaceuticals has filed to raise $100 million in an IPO, although the final figure may differ. The firm is advancing its OP-1250 drug to treat various women's cancers as a monotherapy and in combination with other drugs. OLMA has a collaboration deal with Novartis, which i...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 54.4% to $0.4264 on volume of 158,036,142 shares Versus Systems Inc. (VS) rose 73.5% to $2.29 on volume of 40,036,424 shares Tesla Inc. (TSLA) rose 5.3% to $220.97 on volume of 32,375,487 shar...
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. ...